Cargando…
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216850/ https://www.ncbi.nlm.nih.gov/pubmed/32399895 http://dx.doi.org/10.1007/s12185-020-02888-9 |
| _version_ | 1783532493641613312 |
|---|---|
| author | Takami, Akiyoshi |
| author_facet | Takami, Akiyoshi |
| author_sort | Takami, Akiyoshi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7216850 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72168502020-05-12 Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19 Takami, Akiyoshi Int J Hematol Letter to the Editor Springer Singapore 2020-05-12 2020 /pmc/articles/PMC7216850/ /pubmed/32399895 http://dx.doi.org/10.1007/s12185-020-02888-9 Text en © Japanese Society of Hematology 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Takami, Akiyoshi Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19 |
| title | Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19 |
| title_full | Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19 |
| title_fullStr | Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19 |
| title_full_unstemmed | Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19 |
| title_short | Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19 |
| title_sort | possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216850/ https://www.ncbi.nlm.nih.gov/pubmed/32399895 http://dx.doi.org/10.1007/s12185-020-02888-9 |
| work_keys_str_mv | AT takamiakiyoshi possibleroleoflowdoseetoposidetherapyforhemophagocyticlymphohistiocytosisbycovid19 |